Predictors of leptin concentration and association with cardiovascular risk in patients with coronary artery disease: results from the AtheroGene study

References

• Bluher M. (2012). Clinical relevance of adipokines. Diabetes Metab J 36:317–27
   PubMedGoogle Scholar
• Bluher M, Mantzoros CS. (2015). From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism 64:131–45
   PubMed Web of Science ®Google Scholar
• Bodary PF, Gu S, Shen Y, et al. (2005). Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25:e119–22
   Google Scholar
• Bodary PF, Shen Y, Ohman M, et al. (2007). Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance. Arterioscler Thromb Vasc Biol 27:70–6
   PubMed Web of Science ®Google Scholar
• Brennan AM, Li TY, Kelesidis I, et al. (2007). Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia 50:1178–85
   PubMed Web of Science ®Google Scholar
• Chedraui P, Perez-Lopez FR, Escobar GS, et al. (2014). Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Maturitas 79:86–90
   PubMed Web of Science ®Google Scholar
• Couillard C, Lamarche B, Mauriege P, et al. (1998). Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Diabetes Care 21:782–6
   PubMed Web of Science ®Google Scholar
• Couillard C, Mauriege P, Prud'homme D, et al. (1997). Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia 40:1178–84
   PubMed Web of Science ®Google Scholar
• Devaraj S, Torok N. (2011). Leptin: the missing link between obesity and heart disease? Atherosclerosis 217:322–3.
   PubMed Web of Science ®Google Scholar
• Diez JJ, Iglesias P, Fernandez-Reyes MJ, et al. (2005). Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf) 62:242–9
   PubMed Web of Science ®Google Scholar
• Doucet E, St-Pierre S, Almeras N, et al. (2000). Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: evidence from both a cross-sectional and an intervention study. J Clin Endocrinol Metab 85:4231–7
   PubMed Web of Science ®Google Scholar
• Dubey L, Zeng H, Hashmi S, et al. (2008). Association of plasma leptin levels and complexity of the culprit lesion in patients with unstable angina. Int J Cardiol 126:183–9
   PubMed Web of Science ®Google Scholar
• Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. (2000). Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 12:1712–16
   PubMed Web of Science ®Google Scholar
• Gannage-Yared MH, Khalife S, Semaan M, et al. (2006). Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol 155:167–76
   PubMed Web of Science ®Google Scholar
• Gomez-Ambrosi J, Salvador J, Paramo JA, et al. (2002). Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem 35:315–20
   PubMed Web of Science ®Google Scholar
• Grassi G. (2006). Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertens Res 29:839–47
   PubMed Web of Science ®Google Scholar
• Grassi G, Seravalle G, Colombo M, et al. (1998). Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 97:2037–42
   PubMed Web of Science ®Google Scholar
• Haynes WG. (2005). Role of leptin in obesity-related hypertension. Exp Physiol 90:683–8
   PubMed Web of Science ®Google Scholar
• Iribarren C, Husson G, Go AS, et al. (2007). Plasma leptin levels and coronary artery calcification in older adults. J Clin Endocrinol Metab 92:729–32
   PubMed Web of Science ®Google Scholar
• Khan UI, Ogorodnikova AD, Xu L, et al. (2014). The adipokine profile of metabolically benign obese and at-risk normal weight postmenopausal women: the Women's Health Initiative Observational Study. Obesity (Silver Spring) 22:786–94
   PubMed Web of Science ®Google Scholar
• Ku IA, Farzaneh-Far R, Vittinghoff E, et al. (2011). Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis 217:503–8
   PubMed Web of Science ®Google Scholar
• Mantzoros CS, Moschos SJ. (1998). Leptin: in search of role(s) in human physiology and pathophysiology. Clin Endocrinol (Oxf) 49:551–67
   PubMed Web of Science ®Google Scholar
• Martin SS, Blaha MJ, Muse ED, et al. (2014). Leptin and incident cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 239:67–72
   PubMed Web of Science ®Google Scholar
• Priya T, Chowdhury MG, Vasanth K, et al. (2013). Assessment of serum leptin and resistin levels in association with the metabolic risk factors of pre- and post-menopausal rural women in South India. Diabetes Metab Syndr 7:233–7
   PubMedGoogle Scholar
• Rahmouni K, Haynes WG. (2004). Leptin and the cardiovascular system. Recent Prog Horm Res 59:225–44
   PubMedGoogle Scholar
• Risch L, Saely C, Hoefle G, et al. (2007). Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin Chim Acta 376:108–13
   PubMed Web of Science ®Google Scholar
• Rupprecht HJ, Blankenberg S, Bickel C, et al. (2001). Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104:25–31
   PubMed Web of Science ®Google Scholar
• Sattar N, Wannamethee G, Sarwar N, et al. (2009). Leptin and coronary heart disease: prospective study and systematic review. J Am Coll Cardiol 53:167–75
   PubMed Web of Science ®Google Scholar
• Sheehan FH, Bolson EL, Dodge HT, et al. (1986). Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 74:293–305
   PubMed Web of Science ®Google Scholar
• Soderberg S, Ahren B, Jansson JH, et al. (1999). Leptin is associated with increased risk of myocardial infarction. J Intern Med 246:409–18
   PubMed Web of Science ®Google Scholar
• Soderberg S, Stegmayr B, Stenlund H, et al. (2004). Leptin, but not adiponectin, predicts stroke in males. J Intern Med 256:128–36
   PubMed Web of Science ®Google Scholar
• Wallace AM, McMahon AD, Packard CJ, et al. (2001). Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052–6
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Whincup PH, et al. (2011). Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role? J Am Coll Cardiol 58:1870–7.
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Whincup PH, et al. (2014). The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin. Int J Cardiol 171:49–55
   PubMed Web of Science ®Google Scholar
• Wolk R, Berger P, Lennon RJ, et al. (2003). Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation 108:2206–11
   PubMed Web of Science ®Google Scholar
• Wolk R, Berger P, Lennon RJ, et al. (2004). Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol 44:1819–24
   PubMed Web of Science ®Google Scholar
• Zengin E, Sinning C, Zeller T, et al. (2015). Activity of superoxide dismutase copper/zinc type and prognosis in a cohort of patients with coronary artery disease. Biomark Med 9:597–604
   PubMed Web of Science ®Google Scholar